Page last updated: 2024-08-22

clodronic acid and Non-alcoholic Fatty Liver Disease

clodronic acid has been researched along with Non-alcoholic Fatty Liver Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Hasuzawa, N; Kabashima, M; Nomura, M; Tatsushima, K; Tokubuchi, R1
Bader, JE; Carson, MS; Enos, RT; McGuinness, OP; Murphy, EA; Robinson, CM; Sougiannis, AT; Velázquez, KT1
Akiyoshi, K; Aoe, S; Fukaishi, T; Hamaguchi, M; Itoh, M; Kanai, S; Kato, H; Komohara, Y; Konuma, K; Marumoto, Y; Ogawa, Y; Sakaida, I; Sakugawa, H; Suganami, T; Takeya, M; Terai, S1
Cani, PD; Horsmans, Y; Lanthier, N; Leclercq, IA; Molendi-Coste, O; van Rooijen, N1
Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Tsai, TH; Yang, YY1

Reviews

1 review(s) available for clodronic acid and Non-alcoholic Fatty Liver Disease

ArticleYear
[VNUT Is a Therapeutic Target for Type 2 Diabetes and NASH].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2021, Volume: 141, Issue:4

    Topics: Adenosine Triphosphate; Animals; Clodronic Acid; Diabetes Mellitus, Type 2; Drug Discovery; Humans; Insulin Resistance; Insulin Secretion; Mice, Knockout; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Nucleotide Transport Proteins; Secretory Vesicles

2021

Other Studies

4 other study(ies) available for clodronic acid and Non-alcoholic Fatty Liver Disease

ArticleYear
Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments.
    American journal of physiology. Endocrinology and metabolism, 2019, 03-01, Volume: 316, Issue:3

    Topics: Adipose Tissue; Animals; Body Weight; Clodronic Acid; Cytokines; Diet, Fat-Restricted; Diet, High-Fat; Energy Intake; Insulin Resistance; Lipid Metabolism; Liposomes; Liver; Macrophages; Male; Mice; Neutrophils; Non-alcoholic Fatty Liver Disease; Obesity; RNA, Messenger

2019
Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Animals; Chronic Disease; Clodronic Acid; Fatty Liver; Female; Hepatitis, Viral, Human; Humans; Inflammation; Lipid Metabolism; Liposomes; Liver; Liver Cirrhosis; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Non-alcoholic Fatty Liver Disease; Phenotype; Receptor, Melanocortin, Type 4

2013
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:12

    Topics: Adipose Tissue; Adiposity; Animals; Clodronic Acid; Diet, High-Fat; Fatty Liver; Inflammation; Insulin Resistance; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity

2011
Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
    Clinical science (London, England : 1979), 2012, Volume: 123, Issue:12

    Topics: Analysis of Variance; Animals; Arachidonic Acid; Benzofurans; Choline; Clodronic Acid; Diet, High-Fat; DNA Primers; Fatty Acids, Unsaturated; Fatty Liver; Gadolinium; Hemodynamics; Hypertension, Portal; Insulin Resistance; Kupffer Cells; Leptin; Methionine; Methoxamine; Microcirculation; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Receptors, Thromboxane A2, Prostaglandin H2; RNA, Messenger; Sulfonylurea Compounds; Thiobarbituric Acid Reactive Substances; Thromboxane A2

2012